These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23700930)

  • 1. [Toxicity of triazavirin, a novel Russian antiinfluenza chemotherapeutic].
    Loginova SIa; Borisevich SV; Rusinov VL; Ulomskiĭ UN; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2012; 57(11-12):8-10. PubMed ID: 23700930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture].
    Loginova SIa; Borisevich SV; Rusinov VL; Ulomskiĭ UN; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2014; 59(1-2):3-5. PubMed ID: 25051708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol Inhalation Delivery of Triazavirin in Mice: Outlooks for Advanced Therapy Against Novel Viral Infections.
    Valiulin SV; Onischuk AA; Dubtsov SN; Baklanov AM; An'kov SV; Plokhotnichenko ME; Tolstikova TG; Dultseva GG; Rusinov VL; Charushin VN; Fomin VM
    J Pharm Sci; 2021 Mar; 110(3):1316-1322. PubMed ID: 33249050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new antiviral drug Triazavirin: results of phase II clinical trial].
    Kiselev OI; Deeva EG; Mel'nikova TI; Kozeletskaia KN; Kiselev AS; Rusinov VL; Charushin VN; Chupakhin ON
    Vopr Virusol; 2012; 57(6):9-12. PubMed ID: 23477247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triazavirin prophylactic efficacy against influenza virus A (H5N1)].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Kotovskaia SK; Rusinov VL; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2010; 55(9-10):25-8. PubMed ID: 21400750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic efficacy of Triazavirin, a novel Russian chemotherapeutic, against influenza virus A (H5N1)].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Kotovskaia SK; Rusinov VL; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2011; 56(1-2):10-2. PubMed ID: 21780665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basing approximate safe level of exposure to Triazavirin in air of workplace].
    Lukovnikova LV; Sidorin GI; D'iakova LI; Skhodkina NI; Bitti MA; Cherkashchenko OS
    Med Tr Prom Ekol; 2009; (4):44-7. PubMed ID: 19514171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin.
    Kozhikhova KV; Ivantsova MN; Tokareva MI; Shulepov ID; Tretiyakov AV; Shaidarov LV; Rusinov VL; Mironov MA
    Pharm Dev Technol; 2018 Apr; 23(4):334-342. PubMed ID: 27681534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat oral dose toxicity studies of melamine in rats and monkeys.
    Early RJ; Yu H; Mu XP; Xu H; Guo L; Kong Q; Zhou J; He B; Yang X; Huang H; Hu E; Jiang Y
    Arch Toxicol; 2013 Mar; 87(3):517-27. PubMed ID: 23052191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice].
    Loginova SY; Borisevich SV; Rusinov VL; Ulomsky EN; Charushin VN; Chupakhin ON; Sorokin PV
    Antibiot Khimioter; 2015; 60(7-8):11-3. PubMed ID: 26863736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of Prophylactic Efficacy of Triazavirin Against Experimental Forest- Spring Encephalitis on Albino Mice].
    Loginova SY; Borisevich SV; Rusinov VL; Ulomsky UN; Charushin VN; Chupakhin N; Sorokin PV
    Antibiot Khimioter; 2015; 60(5-6):8-11. PubMed ID: 26852489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazavirin-A Novel Effective Antiviral Drug.
    Chupakhin ON; Rusinov VL; Varaksin MV; Ulomskiy EN; Savateev KV; Butorin II; Du W; Sun Z; Charushin VN
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of triazavirin antiviral activity against influenza A virus (H5N1) in cell culture].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Kotovskaia SK; Rusinov VL; Charushin VN
    Antibiot Khimioter; 2007; 52(11-12):18-20. PubMed ID: 19275052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and repeat-dose toxicity of IDX14184, a nucleotide prodrug with antiviral activity for hepatitis C viral infection, in mice, rats, and monkeys.
    Luo S; Rush R; Standring D
    Hum Exp Toxicol; 2016 May; 35(5):472-90. PubMed ID: 26138064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beagle dog 90-day oral toxicity study of a novel coccidiostat - ethanamizuril.
    Zhang K; Zheng H; Wei S; Wang X; Fei C; Wang C; Liu Y; Zhang L; Xue F; Tang S
    BMC Vet Res; 2020 Nov; 16(1):444. PubMed ID: 33203451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The 3-phase reaction of cells of an MDCK culture to long-term exposure to antiviral chemical preparations].
    Votiakov VI; Erokhina IR; Amvros'eva TV
    Biull Eksp Biol Med; 1989 May; 107(5):595-8. PubMed ID: 2736297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Route-dependent different relations between acute and subacute toxicity of the potential antiviral agent benzoxazolyl-2-formyl-S-ethyl-isothiosemicarbazone in mice.
    Amlacher R
    Pharmazie; 1985 Feb; 40(2):132-3. PubMed ID: 3839080
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary safety studies with calcium elenolate, an antiviral agent.
    Elliott GA; Buthala DA; DeYoung EN
    Antimicrob Agents Chemother (Bethesda); 1969; 9():173-6. PubMed ID: 5396484
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative toxicological assessment of a water-soluble azole administered both orally and by intravenous continuous infusion in cynomolgus monkeys.
    Kobayashi K; Horii I
    J Toxicol Sci; 2002 May; 27(2):107-22. PubMed ID: 12058447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.